BSE 1157.15 NSE 1155.60

Mr Alok Sonig

CEO, US Generics, Head Global R&D & Biosimilars

Mr Alok Sonig is the CEO – US Generics, and Global Head – Generics R&D & Biosimilars at Lupin. In a career spanning over two decades, Sonig built a formidable reputation in building high-performance teams, designing integrated processes and nurturing networks to deliver highest-in-industry growth. He is a board member and treasurer of AAM (Association for Accessible Medicines).

Prior to joining Lupin, Sonig was associated with Dr Reddy’s Labs and Bristol-Myers Squibb. He holds an engineering degree from Punjab Engineering College and a management degree from the American University, Washington.